SCHEMBL24028925

SCHEMBL24028925

N#Cc1ccccc1-c1nc(-c2ccc(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2)nc(-n2c3ccccc3c3ccccc32)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN5 P54829 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ GBA1 P04062 1/20 0.34
▸ GABRG2 P18507 2/20 0.33
▸ GABRB3 P28472 2/20 0.33
▸ GABRA5 P31644 2/20 0.33
▸ GABRA3 P34903 2/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ PPARG P37231 2/20 0.33
▸ TP53 P04637 3/20 0.32
▸ NR3C1 P04150 1/20 0.32
▸ ELANE P08246 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24028686 0.90 GABRG2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL24028853 0.86 ABCG2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL25719460 0.85 ATM (0.39) CYP1A2GBA1TP53MEN1RAB9A
SCHEMBL24028689 0.84 ABCG2 (0.38) GBA1TP53MEN1RAB9AKMT2A
SCHEMBL24028268 0.84 PSD (0.36) PTPN5CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL24028926 0.83 ALDH1A1 (0.35) TP53MEN1RAB9AKMT2ASMN1; SMN2
SCHEMBL23900281 0.83 ATM (0.39) CYP1A2GBA1TP53MEN1RAB9A
SCHEMBL24029061 0.82 USP1 (0.39) GBA1ELANEMEN1KMT2A
SCHEMBL24028852 0.81 CYP1A2 (0.48) PTPN5CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL15308213 0.81 MAPK1 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, SIRT1 PTPN5 4807/4885CYP1A2 250/4885CYP3A4 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback